Russia's Habarovsk Region Refuses to Implement E-Cigarette Ban

Regulations by 2FIRSTS.ai
Feb.20.2024
Russia's Habarovsk Region Refuses to Implement E-Cigarette Ban
The legislative council in Russia's Khabarovsk region rejects e-cigarette ban, citing impracticality and potential black market risks.

The telegram channel of the legislature of the Khabarovsk region in Russia recently stated that the region will not implement a ban on the sale of e-cigarettes, as they believe this measure is impractical.

 

Lawmakers emphasized that e-cigarettes are now being treated equally with other nicotine-containing products, and all restrictions align with those related to tobacco consumption bans. They reasonably inferred that the ban may not have the intended effect and could potentially lead to the sale of unauthorized products.

 

One of the main reasons for the widespread use of e-cigarettes among children and teenagers is the lack of parental supervision and their encouragement.

 

The Russian Consumer Rights Protection Supervisory Authority is responsible for overseeing the enforcement of sales regulations.

 

According to reports, the region of Khabarovsk is located in the Russian Far East, bordering the northeastern region of China.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Complete Vape Prohibition Takes Effect Across Uzbekistan
Complete Vape Prohibition Takes Effect Across Uzbekistan
Uzbekistan has enacted a nationwide ban on the sale and circulation of e-cigarettes and related vape liquids, following the approval of a new law signed by President Shavkat Mirziyoyev. The legislation introduces criminal liability for violations, with penalties including fines of 300 to 500 basic calculation units (approximately US$10,300–17,200), corrective labor for up to three years, or imprisonment for up to five years.
Nov.28 by 2FIRSTS.ai
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
Product | OXVA launches Artio 2 liquid-tobacco pod device, positioned as distinct from HNB and traditional flavored e-cigarettes
OXVA has released its Artio 2 pod device featuring the Liquid Tobacco Intelligent (LTI) platform. It offers around 400 puffs per charge, pods equivalent to about 35 cigarettes, five tobacco and shisha flavors, and a 900mAh battery with 30-minute fast charging. The company positions the device as distinct from HNB and traditional flavored e-cigarettes.
Nov.27 by 2FIRSTS.ai
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus is discussing the introduction of criminal liability for selling vapes and related nicotine-containing products to minors. During a meeting of the expert council, a draft law regulating tobacco and non-tobacco nicotine products received support from most members.
Dec.15 by 2FIRSTS.ai
PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMI Launches IQOS ILUMA i in the Philippines, Debuts via Official Stores and Online Channels
PMFTC, the Philippine affiliate of Philip Morris International (PMI), has introduced the heated tobacco device IQOS ILUMA i in the Philippines, featuring induction-heating technology and multiple smart functions. PMI aims to increase the share of smoke-free products to around 66% of its net revenues by 2030. Previously, PMFTC had already launched ZYN nicotine pouch products in Manila.
Nov.25 by 2FIRSTS.ai
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
On January 20, 2026, the U.S. Food and Drug Administration (FDA) posted meeting materials ahead of a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting scheduled for January 22, 2026, to discuss modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 ZYN nicotine pouch products.
Jan.21 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai